Drug class in one race
AXL drugs for Non-Small Cell Lung Cancer
2 tracked AXL drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the AXL page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 preclinical / unstaged
Head-to-head evidence: AB801 vs CAB-AXL-ADC